Increased prevalence of chronic lymphocytic thyroiditis in Korean patients with papillary thyroid cancer

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Oh, Chang Mo ^a   Park, Sohee ^b   Lee, Joo Young ^c   Won, Young Joo ^a   Shin, Aesun ^d   Kong, Hyun Joo ^a   Choi, Kui Sun ^a   Lee, You Jin ^a   Chung, Ki Wook ^e   Jung, Kyu Won ^a  

^a National Cancer Center   (South Korea)

^b Yonsei University   (South Korea)

^c National Medical Center   (South Korea)

^d Seoul National University   (South Korea)

^e Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER SIZE; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEMALE; HASHIMOTO DISEASE; HUMAN; KOREAN (PEOPLE); MALE; RETROSPECTIVE STUDY; SEX DIFFERENCE; THYROID CARCINOMA; CARCINOMA; COMPLICATION; MIDDLE AGED; PATHOLOGY; PREVALENCE; REGRESSION ANALYSIS; SOUTH KOREA; THYROID TUMOR; YOUNG ADULT;

ADULT; AGED; CARCINOMA; FEMALE; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SEX FACTORS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84903122591     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099054     Document Type: Article

References (40)

1. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, et al. (2009) International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 20: 525-531.
2. Ferlay J, Soerjomataram I, Ervik M (2012) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet], International Agency for Research on Cancer, 2013. Available: http://globocan.iarc.fr/. Accessed 11 January 2013.
3. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, et al. (2013) Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 45: 1-14.
4. Cho BY, Choi HS, Park YJ, Lim JA, Ahn HY, et al. (2013) Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid 23: 797-804.
5. The Korea Central Cancer Registry, National Cancer Center (2012) Annual report of cancer statistics in Korea in 2010. Sejong City: Ministry of Health and Welfare. 182 p.
6. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, et al. (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 18: 784-791.
7. Leese GP, Flynn RV, Jung RT, Macdonald TM, Murphy MJ, et al. (2008) Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clin Endocrinol (Oxf) 68: 311-316.
8. Benvenga S, Trimarchi F (2008) Changed presentation of Hashimoto's thyroiditis in North-Eastern Sicily and Calabria (Southern Italy) based on a 31-year experience. Thyroid 18: 429-441. (Pubitemid 351519545)
9. Statistics Korea. Available: http://kosis.kr/. Accessed 2 January 2013.
10. Cunha LL, Ferreira RC, Marcello MA, Vassallo J, Ward LS (2011) Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer. J Thyroid Res 2011: 387062. Available: http://www.hindawi.com/journals/jtr/2011/387062. Accessed 10 February 2013.
11. Feldt-Rasmussen U, Rasmussen AK (2010) Autoimmunity in differentiated thyroid cancer: significance and related clinical problems. Hormones 9: 109-117.
12. Zhumadilov Z, Gusev BI, Takada J, Hoshi M, Kimura A, et al. (2000) Thyroid abnormality trend over time in northeastern regions of Kazakhstan, adjacent to the Semipalatinsk nuclear test site: a case review of pathological findings for 7271 patients. J Radiat Res 41: 35-44.
13. Harach HR, Escalante DA, Day ES (2002) Thyroid cancer and thyroiditis in Salta, Argentina: a 40-yr study in relation to iodine prophylaxis. Endocr Pathol 13: 175-181. (Pubitemid 36021029)
14. Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, et al. (2010) Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab 95: 1516-1527.
15. Pagano L, Caputo M, Sama MT, Garbaccio V, Zavattaro M, et al. (2012) Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carita" in Novara. Endocrine 42: 382-390.
16. Dong W, Zhang H, Zhang P, Li X, He L, et al. (2013) The changing incidence of thyroid carcinoma in Shenyang, China before and after universal salt iodization. Med Sci Monit 19: 49-53.
17. Caturegli P, De Remigis A, Chuang K, Dembele M, Iwama A, et al. (2013) Hashimoto's thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. Thyroid 23: 142-150.
18. Oh CM, Jung KW, Won YJ, Shin A, Kong HJ, et al. (2013) Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009. PloS One 8: e72012.
19. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, et al. (2007) Cancer incidence in five continents, Vol. IX. IARC Scientific Publications No. 160. Lyon: International Agency for Research on Cancer. 10 p.
20. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, et al. (2002) AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag Press.
21. Cibas ES, Ali SZ (2009) The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 19: 1159-1165.
22. Kwak JY, Kim E, Youk JH, Kim MJ, Son EJ, et al. (2008) Extrathyroid extension of well-differentiated papillary thyroid microcarcinoma on US. Thyroid 18: 609-614. (Pubitemid 351918452)
23. Chow S, Law SC, Chan JK, Au S, Yau S, et al. (2003) Papillary microcarcinoma of the thyroid - prognostic significance of lymph node metastasis and multifocality. Cancer 98: 31-40. (Pubitemid 36741122)
24. Thompson ML, Myers JE, Kriebel D (1998) Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? Occup Environ Med 55: 272-277. (Pubitemid 28179979)
25. Loh K, Greenspan FS, Dong F, Miller TR, Yeo PP (1999) Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84: 458-463. (Pubitemid 29075669)
26. Repplinger D, Bargren A, Zhang Y, Adler JT, Haymart M, et al. (2008) Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res 150: 49-52.
27. Kim YS, Choi H, Kim ES (2013) Papillary thyroid carcinoma with thyroiditis: Lymph node metastasis, complications. J Korean Surg Soc 85: 20-24.
28. Konturek A, Barczyński M, Nowak W, Wierzchowski W (2014) Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto's thyroiditis. Langenbecks Arch Surg 399:229-236.
29. Lee JH, Kim Y, Choi JW, Kim YS (2013) The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis. Eur J Endocrinol 168: 343-349.
30. Teng W, Shan Z, Teng X, Guan H, Li Y, et al. (2006) Effect of iodine intake on thyroid diseases in China. N Engl J Med 354: 2783-2793. (Pubitemid 43974196)
31. Blomberg M, Feldt-Rasmussen U, Andersen KK, Kjaer SK (2012) Thyroid cancer in Denmark 1943-2008, before and after iodine supplementation. Int J Cancer 131: 2360-2366.
32. Kim JY, Moon SJ, Kim KR, Sohn CY, Oh JJ (1998) Dietary iodine intake and urinary iodine excretion in normal Korean adults. Yonsei Med J 39: 355-362. (Pubitemid 28419010)
33. Korea Centers for Disease Control and Prevention (2012) Korean National Health and Nutrition Examination Survey, 1998-2011. Available from http://knhanes.cdc.go.kr. Accessed 10 February 2014.
34. Peterson E, De P, Nuttall R (2012) BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PloS One 7: e29177.
35. Michikawa T, Inoue M, Shimazu T, Sawada N, Iwasaki M, et al. (2012) Seaweed consumption and the risk of thyroid cancer in women: the Japan Public Health Center-based Prospective Study. Eur J Cancer Prev 21: 254-260.
36. Grodski S, Brown T, Sidhu S, Gill A, Robinson B, et al. (2008) Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144: 1038-1043.
37. Li N, Du XL, Reitzel LR, Xu L, Sturgis EM (2013) Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the Surveillance, Epidemiology, and End Results registry, 1980-2008. Thyroid 23: 103-110.
38. Morris LG, Sikora AG, Tosteson TD, Davies L (2013) The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 23: 885-891.
39. Morris LG, Myssiorek D (2010) Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 200: 454-461.
40. Rego-Iraeta A, Perez-Mendez LF, Mantinan B, Garcia-Mayor RV (2009) Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid 19: 333-340.